![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for... XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States. Show more
AUSTIN, Texas, June 18, 2024 (GLOBE NEWSWIRE) -- XBiotechΒ (NASDAQ: XBIT) announced today data from its Phase 1/Phase 2 randomized, double-blind, placebo-controlled multi-center study for...
AUSTIN, Texas, Jan. 04, 2024 (GLOBE NEWSWIRE) -- XBiotech Inc. today announced that it plans to expand itβs campus headquarters with the construction of a new, state-of-the-art research and...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.06 | -1.15163147793 | 5.21 | 5.47 | 4.3901 | 164809 | 4.85975736 | CS |
4 | -2.39 | -31.6976127321 | 7.54 | 7.89 | 4.3901 | 123307 | 5.72359167 | CS |
12 | -3.38 | -39.6248534584 | 8.53 | 9.96 | 4.3901 | 97239 | 7.39397134 | CS |
26 | 1.25 | 32.0512820513 | 3.9 | 9.96 | 3.83 | 71431 | 6.99820322 | CS |
52 | -0.92 | -15.1565074135 | 6.07 | 9.96 | 3.51 | 45507 | 6.4906333 | CS |
156 | -12.07 | -70.0929152149 | 17.22 | 18.46 | 3 | 62797 | 7.87243166 | CS |
260 | -2.45 | -32.2368421053 | 7.6 | 33.2 | 3 | 135596 | 14.42309733 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions